Hims & Hers Health Inc. (HIMS) is priced at $12.74 after the most recent trading session. At the very opening of the session, the stock price was $15.34 and reached a high price of $15.3514, prior to closing the session it reached the value of $13.45. The stock touched a low price of $13.36.
Recently in News on June 9, 2021, Miley Cyrus Joins Hims & Hers as Creative Advisor. Company Is Teaming Up With The Multi-Platinum Selling Recording Artist, Songwriter and Trailblazer to Shine a Spotlight On Personalized Skincare . You can read further details here
Hims & Hers Health Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $25.40 on 02/08/21, with the lowest value was $8.09 for the same time period, recorded on 05/13/21.
Hims & Hers Health Inc. (HIMS) full year performance was 34.23%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Hims & Hers Health Inc. shares are logging -49.84% during the 52-week period from high price, and 57.44% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.09 and $25.40.
The company’s shares, operating in the sector of Consumer Defensive managed to top a trading volume set approximately around 900314 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Hims & Hers Health Inc. (HIMS) recorded performance in the market was -7.88%, having the revenues showcasing 1.74% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.46B, as it employees total of 181 workers.
Analysts verdict on Hims & Hers Health Inc. (HIMS)
During the last month, 1 analysts gave the Hims & Hers Health Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 14.46, with a change in the price was noted -5.10. In a similar fashion, Hims & Hers Health Inc. posted a movement of -28.27% for the period of last 100 days, recording 1,996,646 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HIMS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Hims & Hers Health Inc. (HIMS): Technical Analysis
Raw Stochastic average of Hims & Hers Health Inc. in the period of last 50 days is set at 65.00%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 65.00%. In the last 20 days, the company’s Stochastic %K was 78.05% and its Stochastic %D was recorded 87.14%.
Let’s take a glance in the erstwhile performances of Hims & Hers Health Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -7.88%. Additionally, trading for the stock in the period of the last six months notably improved by 13.79%, alongside a boost of 34.23% for the period of the last 12 months. The shares increased approximately by -1.75% in the 7-day charts and went down by 30.33% in the period of the last 30 days. Common stock shares were driven by 1.74% during last recorded quarter.